Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks

被引:22
|
作者
El-Gamal, Mohamed [1 ,2 ]
Salama, Mohamed [1 ,2 ,3 ]
Collins-Praino, Lyndsey E. [4 ]
Baetu, Irina [4 ]
Fathalla, Ahmed M. [5 ]
Soliman, Amira M. [5 ]
Mohamed, Wael [6 ,7 ]
Moustafa, Ahmed A. [8 ,9 ,10 ]
机构
[1] Mansoura Univ, Toxicol Dept, Fac Med, Mansoura, Egypt
[2] Mansoura Univ, Med Expt Res Ctr MERC, Fac Med, Mansoura, Egypt
[3] Trinity Coll Dublin TCD, Global Brain Hlth Inst GBHI, Dublin, Ireland
[4] Univ Adelaide, Adelaide, SA, Australia
[5] Suez Canal Univ, Dept Pharmacol, Fac Med, Ismailia, Egypt
[6] Menoufia Univ, Clin Pharmacol Dept, Fac Med, Mansoura, Egypt
[7] Int Islamic Univ, Dept Basic Med Sci, Kulliyyah Med, Kuantan, Pahang, Malaysia
[8] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia
[9] Western Sydney Univ, Marcs Inst Brain & Behav, Sydney, NSW, Australia
[10] Univ Johannesburg, Dept Human Anat & Physiol, Fac Hlth Sci, Johannesburg, South Africa
关键词
Parkinsonian; Toxins; Pesticides; Dopamine; Animal models; Epigenetics;
D O I
10.1007/s12640-021-00356-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by cardinal motor impairments, including akinesia and tremor, as well as by a host of non-motor symptoms, including both autonomic and cognitive dysfunction. PD is associated with a death of nigral dopaminergic neurons, as well as the pathological spread of Lewy bodies, consisting predominantly of the misfolded protein alpha-synuclein. To date, only symptomatic treatments, such as levodopa, are available, and trials aiming to cure the disease, or at least halt its progression, have not been successful. Wong et al. (2019) suggested that the lack of effective therapy against neurodegeneration in PD might be attributed to the fact that the molecular mechanisms standing behind the dopaminergic neuronal vulnerability are still a major scientific challenge. Understanding these molecular mechanisms is critical for developing effective therapy. Thirty-five years ago, Calne and William Langston (1983) raised the question of whether biological or environmental factors precipitate the development of PD. In spite of great advances in technology and medicine, this question still lacks a clear answer. Only 5-15% of PD cases are attributed to a genetic mutation, with the majority of cases classified as idiopathic, which could be linked to exposure to environmental contaminants. Rodent models play a crucial role in understanding the risk factors and pathogenesis of PD. Additionally, well-validated rodent models are critical for driving the preclinical development of clinically translatable treatment options. In this review, we discuss the mechanisms, similarities and differences, as well as advantages and limitations of different neurotoxin-induced rat models of PD. In the second part of this review, we will discuss the potential future of neurotoxin-induced models of PD. Finally, we will briefly demonstrate the crucial role of gene-environment interactions in PD and discuss fusion or dual PD models. We argue that these models have the potential to significantly further our understanding of PD.
引用
收藏
页码:897 / 923
页数:27
相关论文
共 50 条
  • [31] Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement
    Hu, XiaoLong
    Song, Qi
    Li, Xin
    Li, DanDan
    Zhang, Qiao
    Meng, WeiHong
    Zhao, QingChun
    NEUROPHARMACOLOGY, 2017, 117 : 352 - 363
  • [32] Are rodent models of Parkinson's disease behaving as they should?
    Vingill, Siv
    Connor-Robson, Natalie
    Wade-Martins, Richard
    BEHAVIOURAL BRAIN RESEARCH, 2018, 352 : 133 - 141
  • [33] Gastrointestinal dysmotility in rodent models of Parkinson's disease
    Pellegrini, Carolina
    Travagli, R. Alberto
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2024, 326 (04): : G345 - G359
  • [34] Sleep Disorders in Rodent Models of Parkinson's Disease
    Medeiros, Daniel de Castro
    Aguiar, Cleiton Lopes
    Dutra Moraes, Marcio Flavio
    Fisone, Gilberto
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons
    Beske, Phillip H.
    Bradford, Aaron B.
    Grynovicki, Justin O.
    Glotfelty, Elliot J.
    Hoffman, Katie M.
    Hubbard, Kyle S.
    Tuznik, Kaylie M.
    McNutt, Patrick M.
    TOXICOLOGICAL SCIENCES, 2016, 149 (02) : 503 - 515
  • [36] Parkinson's disease rodent models: Are they suitable for DBS research?
    Merino Ruiz, Miguel Cesar
    Guimaraes, Rayanne Poletti
    Mortari, Marcia Renata
    JOURNAL OF NEUROSCIENCE METHODS, 2022, 380
  • [37] Sensory neuropathy and nociception in rodent models of Parkinson's disease
    Valek, Lucie
    Auburger, Georg
    Tegeder, Irmgard
    DISEASE MODELS & MECHANISMS, 2019, 12 (06)
  • [38] Rodent models of Parkinson's disease: beyond the motor symptomatology
    Campos, Filipa L.
    Carvalho, Miguel M.
    Cristovao, Ana C.
    Je, Goun
    Baltazar, Graca
    Salgado, Antonio J.
    Kim, Yoon-Seong
    Sousa, Nuno
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2013, 7
  • [39] Chagas' disease parasite neurotrophic factor ameliorates neurotoxin-induced degeneration in vivo
    Caradonna, Kacey
    PereiraPerrin, Mercio
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (05): : 515 - 515
  • [40] Chagas' disease parasite neurotrophic factor ameliorates neurotoxin-induced degeneration in vivo
    Caradonna, Kacey
    PereiraPerrin, Mercio
    FASEB JOURNAL, 2008, 22